products

Novel Coronavirus Pneumonia Treatment Drugs Arbidol CAS 131707-25-0 Anti Influenza Virus

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Pneumonia Treatment Drugs - 4
Minimum Order Quantity: 25KGS
Price: Negotiation
Packaging Details: Aluminum foil bag , fiber can , kraft paper bag , plastic drum , 1kg/ bag or 25kg/ drum or as required
Delivery Time: Within 7 days
Payment Terms: T/T, Western Union
Supply Ability: 200-300 MTS/month
Detail Information
Name: Arbidol CAS: 131707-25-0
Form: Powder Molecular Formula: C22H25BrN2O3S
Molecular Weight: 531.89 Type: Pneumonia Treatment Drugs
High Light:

anti pneumonia drugs

,

chloroquine diphosphate


Product Description

Arbidol CAS 131707-25-0 Pneumonia Treatment Drugs

 

Description:

 

Abidol is a dual effect anti influenza virus drug developed by the former Soviet Pharmaceutical Chemistry Research Center, which can simultaneously fight influenza A and B caused by influenza virus, and has antiviral activity against other respiratory virus infections. It was first listed in Russia in 1993 to prevent and treat influenza and other acute respiratory virus infections. The latest research shows that abidol can effectively inhibit the new pneumonia coronavirus.

 

Specifications:

 

Test Items Specification Test Results
Appearance White powder White powder
Melting point 125~127°C Conforms
Specific Rotation +28°~+30° +29°
Acidity(PH) 5.2~6.5 5.8~6.2
Water 4.0%~5.5% 5.00%
Residue On Ignition Not more than 0.1% Conforms
N.N - dimethylaniline Comply with the standard Conforms
Phenolic Compounds Comply with the standard Conforms
Related Substance Comply with the standard Conforms
Assay Between99.0~102.0% 99.53%
Conclusion This batch is complies with USP 41

 

Application:

 

Abidol is suitable for the prevention and treatment of influenza A, influenza B, acute viral respiratory infection and severe acute respiratory syndrome in adults and children, including bronchitis and pneumonia. The use of abidol hydrochloride in the early stage after the onset of influenza can significantly shorten the duration of the disease and reduce the severity of the symptoms. It has a significant effect on improving the symptoms of influenza patients, such as cough, headache, fever, chills, sweating, sore throat, muscle pain, chemical book and fatigue, and it is safe and suitable for clinical application. Usage and dosage: 100mg / capsule, oral, 2 capsules per time for children and adults over 13 years old, 1 capsule per time for children aged 6-12 years old, and 50mg per time for children aged 2-6 years old. Treatment: 3 times a day for 3-5 days. Prevention: take once every three days for three weeks in the epidemic period of influenza; take once a day for two weeks in high-risk groups contacting patients.

On February 4, 2020, Li Lanjuan, academician of Chinese Academy of engineering and member of the high level expert group of the national health and Health Commission, said that according to the preliminary test, in vitro cell experiments showed that abidol at 10-30 micromolar concentration, compared with the untreated control group, could effectively inhibit the coronary virus up to 60 times, and significantly inhibit the pathological effect of the virus on cells.

 

Our strengths:

 

We can customize according to customer's requirement.

If you have any question pls mail us or call us.

 

Contact Details
Fedor

Phone Number : +86 18989305995

WhatsApp : +18989305995